dc.contributor.author | Karaca, Emine Esra | |
dc.contributor.author | Ozdek, Sengul | |
dc.contributor.author | Ozmen, Mehmet Cuneyt | |
dc.contributor.author | Dursun, Ayhan | |
dc.contributor.author | Yalcin, Nuriye Gokcen | |
dc.date.accessioned | 2019-07-27T12:10:23Z | |
dc.date.accessioned | 2019-07-28T09:46:50Z | |
dc.date.available | 2019-07-27T12:10:23Z | |
dc.date.available | 2019-07-28T09:46:50Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 0271-3683 | |
dc.identifier.issn | 1460-2202 | |
dc.identifier.uri | https://dx.doi.org/10.3109/02713683.2015.1039652 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/7584 | |
dc.description | WOS: 000375400100010 | en_US |
dc.description | PubMed ID: 26125968 | en_US |
dc.description.abstract | Purpose: To evaluate safety, efficacy and postoperative characteristics of polyacrylamide 1.5% ophthalmic viscosurgical device (OVD) left in anterior chamber during and at the end of combined phacoemulsification and pars plana vitrectomy surgery. Materials and Methods: This prospective study comprised 20 eyes that received combined phacoemulsification and pars plana vitrectomy performed by the same surgeon. Polyacrylamide 1.5% was left in anterior chamber at the end of the surgery. Preoperative and postoperative examinations (4, 12 and 24 hours; 14 days; 1 and 3 months) included measurement of intraocular pressure (IOP), central corneal thickness (CCT), endothelial cell density and assessment of any ocular adverse reactions. Results : Four of the 20 patients (20%) showed increased IOP at hours postoperatively and needed medical treatment for IOP control. There was no significant difference in IOP between the preoperative visit and postoperative 3 months (p>0.05). CCT measurements were similar between preoperative and postoperative visits (p>0.05). A mean endothelial cell density loss of 6.7% was observed at postoperative day 14, however there was no change after this visit. Conclusion: Polyacrylamide 1.5% is safe, well-tolerated and protective in eyes undergoing combined phacoemulsification and pars plana vitrectomy. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | TAYLOR & FRANCIS INC | en_US |
dc.relation.isversionof | 10.3109/02713683.2015.1039652 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Combined cataract and pars plana vitrectomy | en_US |
dc.subject | intraocular pressure | en_US |
dc.subject | ophthalmic viscosurgical device | en_US |
dc.subject | polyacrylamide | en_US |
dc.subject | viscoelastic | en_US |
dc.title | Safety of Polyacrylamide 1.5% Left in Anterior Chamber in Combined Phacoemulsification and Pars Plana Vitrectomy Surgery | en_US |
dc.type | article | en_US |
dc.relation.journal | CURRENT EYE RESEARCH | en_US |
dc.contributor.department | [Karaca, Emine Esra -- Ozdek, Sengul -- Ozmen, Mehmet Cuneyt -- Yalcin, Nuriye Gokcen] Gazi Univ, Fac Med, Dept Ophthalmol, Ankara, Turkey -- [Karaca, Emine Esra] Sorgun State Hosp, Dept Ophthalmol, Yozgat, Turkey -- [Dursun, Ayhan] Cumhuriyet Univ, Dept Ophthalmol, Fac Med, Sivas, Turkey | en_US |
dc.identifier.volume | 41 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.endpage | 506 | en_US |
dc.identifier.startpage | 501 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |